EGFR and breast carcinoma: Such aberrant EGFR phosphorylation, caused by direct crosstalk between EGFR and other receptor tyrosine kinases or indirectly with the help of Src creating docking sites for EGFR interaction, is considered a mechanism leading to intrinsic resistance of breast cancer to EGFR TKIs.